S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|CIT Serves as Sole Lead Arranger in $110 Million Financing for Epic Health Services (2013/11/19)|
|EPIC Is Pro-Shareholder, and EPIC Changes Exchange Rate From 3 1/2 to 3 Shares for 1 Share of EPIC's Cumulative Convertible Preferred Stock (2013/11/21)|
|EPIC Earns $1,827,877 or $0.17 per Share for 9 Months and EPIC's Focus Builds Shareholder Capital ()|
|EPIC Earns $0.17 per Share, Has a Book Value of $0.67 per Share and a Return on Equity of 176%, and Offers to Exchange One Convertible Preferred Share for 3 1/2 Shares of Common Stock (2013/10/31)|
|ARIAD Reaches 50 Percent Patient Enrollment in Phase 3 EPIC Trial of Iclusig (2013/9/4)|
|Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products (2013/10/8)|
|ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia (2013/10/18)|
|Life Time Announces Schedule and Registration for EPIC, Ultra-Distance Leadman Tri (2013/10/31)|
|Disney's Marvel and Netflix Join Forces to Develop Historic Four Series Epic plus a Miniseries Event Based on Renowned Marvel Characters (2013/11/7)|
|Panasonic Avionics Announces Agreement with Intelsat to Support In-Flight Wi-Fi, Mobile Phone Services and Global Television on Flights Over One of the Fastest Growing Air Travel Regions in the World (2013/9/11)|
Click above to view more mutual fund data and stats for epor - Epic Corporation.